AP511A - The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV). - Google Patents
The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV). Download PDFInfo
- Publication number
- AP511A AP511A APAP/P/1994/000626A AP9400626A AP511A AP 511 A AP511 A AP 511A AP 9400626 A AP9400626 A AP 9400626A AP 511 A AP511 A AP 511A
- Authority
- AP
- ARIPO
- Prior art keywords
- placebo
- granisetron
- vomiting
- ponv
- nausea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Treatment Of Sludge (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939305593A GB9305593D0 (en) | 1993-03-18 | 1993-03-18 | Pharmaceuticals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9400626A0 AP9400626A0 (en) | 1994-04-30 |
| AP511A true AP511A (en) | 1996-07-26 |
Family
ID=10732290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1994/000626A AP511A (en) | 1993-03-18 | 1994-03-16 | The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV). |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5952340A (da) |
| EP (1) | EP0689437B1 (da) |
| JP (2) | JP3792251B2 (da) |
| KR (1) | KR100315606B1 (da) |
| CN (1) | CN1085079C (da) |
| AP (1) | AP511A (da) |
| AT (1) | ATE230596T1 (da) |
| AU (1) | AU676032B2 (da) |
| CA (1) | CA2158354C (da) |
| CY (1) | CY2427B1 (da) |
| DE (1) | DE69431986T2 (da) |
| DK (1) | DK0689437T3 (da) |
| ES (1) | ES2188611T3 (da) |
| GB (1) | GB9305593D0 (da) |
| HK (1) | HK1012237A1 (da) |
| HU (1) | HU214629B (da) |
| IL (1) | IL109059A (da) |
| SG (1) | SG46724A1 (da) |
| TW (1) | TW312622B (da) |
| WO (1) | WO1994021257A1 (da) |
| ZA (1) | ZA941844B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9412995D0 (en) * | 1994-06-28 | 1994-10-26 | Prendergast Kenneth F | Safety enhancing pharmaceutical compositions of an active indazole |
| AU2003237657A1 (en) * | 2002-05-24 | 2003-12-12 | Epidauros Biotechnologie Ag | Means and methods for improved treatment using "setrones" |
| SE0203410D0 (sv) * | 2002-11-18 | 2002-11-18 | Astrazeneca Ab | New use |
| JO2735B1 (en) * | 2003-01-30 | 2013-09-15 | هيلسين هيلث كير أس ايه. | Liquid pharmaceutical formations of balloonosterone |
| TWI355936B (en) | 2003-02-18 | 2012-01-11 | Helsinn Healthcare Sa | Uses of palonosetron hydrochloride |
| GB0328186D0 (en) * | 2003-12-05 | 2004-01-07 | West Pharm Serv Drug Res Ltd | Intranasal compositions |
| JP6081102B2 (ja) * | 2012-08-10 | 2017-02-15 | テルモ株式会社 | 安定なグラニセトロン含有水性製剤 |
| GB201618425D0 (en) * | 2016-11-01 | 2016-12-14 | Acacia Pharma Ltd | method |
| JP2017077484A (ja) * | 2016-11-30 | 2017-04-27 | テルモ株式会社 | 安定なグラニセトロン含有水性製剤の包装体 |
| GB201702250D0 (en) | 2017-02-10 | 2017-03-29 | Acacia Pharma Ltd | Method |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8525913D0 (en) * | 1985-10-21 | 1985-11-27 | Beecham Group Plc | Compounds |
| DE3650772T2 (de) * | 1985-04-27 | 2003-04-03 | F. Hoffmann-La Roche Ag, Basel | Derivate von Indazole-3-carboxamide und -3-carboxylsäure |
| GB8928837D0 (en) * | 1989-12-21 | 1990-02-28 | Beecham Group Plc | Pharmaceuticals |
| US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
| EP0919245A3 (en) * | 1991-09-20 | 2000-11-15 | Glaxo Group Limited | NK-1 receptor antagonist and a systemic antiinflammatory corticosteroid for the treatment of emesis |
-
1993
- 1993-03-18 GB GB939305593A patent/GB9305593D0/en active Pending
-
1994
- 1994-03-15 AU AU63774/94A patent/AU676032B2/en not_active Expired
- 1994-03-15 JP JP52064194A patent/JP3792251B2/ja not_active Expired - Lifetime
- 1994-03-15 AT AT94911178T patent/ATE230596T1/de not_active IP Right Cessation
- 1994-03-15 EP EP94911178A patent/EP0689437B1/en not_active Revoked
- 1994-03-15 SG SG1996009426A patent/SG46724A1/en unknown
- 1994-03-15 KR KR1019950703945A patent/KR100315606B1/ko not_active IP Right Cessation
- 1994-03-15 DE DE69431986T patent/DE69431986T2/de not_active Revoked
- 1994-03-15 WO PCT/EP1994/000820 patent/WO1994021257A1/en active IP Right Grant
- 1994-03-15 ES ES94911178T patent/ES2188611T3/es not_active Expired - Lifetime
- 1994-03-15 DK DK94911178T patent/DK0689437T3/da active
- 1994-03-15 US US08/525,521 patent/US5952340A/en not_active Expired - Lifetime
- 1994-03-15 HU HU9502692A patent/HU214629B/hu unknown
- 1994-03-15 CA CA002158354A patent/CA2158354C/en not_active Expired - Lifetime
- 1994-03-16 AP APAP/P/1994/000626A patent/AP511A/en active
- 1994-03-16 ZA ZA941844A patent/ZA941844B/xx unknown
- 1994-03-21 IL IL10905994A patent/IL109059A/en not_active IP Right Cessation
- 1994-04-06 TW TW083102963A patent/TW312622B/zh not_active IP Right Cessation
- 1994-09-29 CN CN94192028A patent/CN1085079C/zh not_active Expired - Lifetime
-
1998
- 1998-12-15 HK HK98113470A patent/HK1012237A1/xx not_active IP Right Cessation
-
2004
- 2004-02-25 CY CY0400013A patent/CY2427B1/xx unknown
-
2005
- 2005-12-13 JP JP2005359022A patent/JP2006083190A/ja active Pending
Non-Patent Citations (1)
| Title |
|---|
| NONE * |
Also Published As
| Publication number | Publication date |
|---|---|
| IL109059A (en) | 1996-11-14 |
| EP0689437B1 (en) | 2003-01-08 |
| ZA941844B (en) | 1995-09-18 |
| HUT73502A (en) | 1996-08-28 |
| HU214629B (hu) | 1998-04-28 |
| SG46724A1 (en) | 1998-02-20 |
| JPH08507774A (ja) | 1996-08-20 |
| KR100315606B1 (ko) | 2002-04-24 |
| EP0689437A1 (en) | 1996-01-03 |
| JP2006083190A (ja) | 2006-03-30 |
| GB9305593D0 (en) | 1993-05-05 |
| TW312622B (da) | 1997-08-11 |
| JP3792251B2 (ja) | 2006-07-05 |
| CN1085079C (zh) | 2002-05-22 |
| DK0689437T3 (da) | 2003-04-28 |
| WO1994021257A1 (en) | 1994-09-29 |
| AP9400626A0 (en) | 1994-04-30 |
| CA2158354A1 (en) | 1994-09-29 |
| ATE230596T1 (de) | 2003-01-15 |
| AU6377494A (en) | 1994-10-11 |
| ES2188611T3 (es) | 2003-07-01 |
| CY2427B1 (en) | 2004-11-12 |
| IL109059A0 (en) | 1994-11-28 |
| CN1122570A (zh) | 1996-05-15 |
| AU676032B2 (en) | 1997-02-27 |
| DE69431986D1 (de) | 2003-02-13 |
| CA2158354C (en) | 2004-07-13 |
| HU9502692D0 (en) | 1995-11-28 |
| US5952340A (en) | 1999-09-14 |
| DE69431986T2 (de) | 2003-11-06 |
| HK1012237A1 (en) | 1999-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940011246B1 (ko) | 로라타딘, 이부프로펜 및 슈도에페드린을 함유하는 약제학적 조성물 | |
| CA1288350C (en) | Controlled release dihydrocodeine composition | |
| US20040234593A1 (en) | Diphenhydramine tannate compositions and methods of use | |
| DE60009697T2 (de) | Verwendung von 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazin und dessen physiologisch akzeptablen salzen zur behandlung von bipolaren krankheiten und manie | |
| AP511A (en) | The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV). | |
| AU674335B2 (en) | Ophthalmological preparation | |
| DE19858789A1 (de) | Kombination von Cerivastatin und Fibraten | |
| JPH0320222A (ja) | 脳内虚血症治療剤 | |
| US20060160887A1 (en) | Medicinal composition | |
| JPH07508745A (ja) | （ｓ）−チモロール半水和物を含有する局所眼科治療用組成物及びその製造方法 | |
| JP3150642B2 (ja) | 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法 | |
| WO1998038997A1 (en) | Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia | |
| JP2022533510A (ja) | グリコピロレートを含む口腔内崩壊錠剤および生物学的利用率を増大させるための方法 | |
| CA2002552C (en) | Pharmaceutical aqueous solution for ophthalmic use comprising a water solube pharmaceutically acceptable acid addition salt of ibopamine | |
| US4062974A (en) | Method for treating drepanocytosis | |
| JPS63502270A (ja) | 散瞳作用を有する眼科用医薬組成物 | |
| US6162792A (en) | Use of spiramycin for treating gastrointestinal disorders caused by H. pylori | |
| CN1309564A (zh) | 治疗方法 | |
| US5990134A (en) | Oral droperidol compositions and method for treating migraine | |
| WO2024062443A1 (en) | Pharmaceutical compositions | |
| EP0723448A1 (en) | Use of peniclorin for the treatment of posttherapeutic neuralgia | |
| JPH0132804B2 (da) | ||
| JP2001253825A (ja) | 帯状疱疹後神経痛用鎮痛剤 | |
| MXPA01000466A (en) | Method of treatment |